Delivery Order SPE2DB20D3103-SPE2DB25FM3C8
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, SPE2DB20D3103|SPE2DB24FM2U3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,579.89 firm fixed price delivery order is for the supply of 4563324182 ! REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication product. The award has an ultimate completion date of January 16, 2024 and was issued on January 12, 2024. This award is not designated as a set-aside...
This federal contract award, with an ID of SPE2DB20D3103 and SPE2DB22FP1W2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,466.06 firm fixed-price delivery order is for the supply of 4557782755 - REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, with a completion date of July 14, 2022. This contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $31,971.06 for the medical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The award has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $13,021.65 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
This federal contract award, valued at $4,101.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC), covers the provision of REBIF SYR 0.5ML 12S, a pharmaceutical product. The contract has a firm fixed price and is set to run until November 13, 2024. While the original solicitation is not provided, the contract appears to be part of a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,217.78 and is a Firm Fixed Price Delivery Order, with a period of performance ending on March 5, 2024. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. This contract award is not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award, valued at $21,075.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. As a general...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product, REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML. The contract has a ceiling value of $8,206.68 and is a firm fixed price delivery order that will run through August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this critical medical commodity to support military treatment programs and federal healthcare providers. This order is...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $63,542.35 firm fixed-price delivery order is for the supply of REBIF 44 MCG/0.5 ML syringes, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of...